SMTL ID : 4tzc.1 (3 other biounits)

Crystal Structure of Murine Cereblon in Complex with Thalidomide

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.88 Å

Oligo State

monomer

Ligands

1 x ZN: ZINC ION(Non-covalent)

ZN.1: 4 residues within 4Å: Chain A: C.6, C.9, C.74, C.77 4 PLIP interactions: 4 interactions with chain A Metal complexes: A:C.6, A:C.9, A:C.74, A:C.77

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.2: 3 residues within 4Å: Chain A: S.93, P.94, Q.95 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Q.95 SO4.3: 1 residues within 4Å: Chain A: H.61 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:H.61 Salt bridges: A:H.61

1 x EF2: S-Thalidomide(Non-covalent)

EF2.4: 7 residues within 4Å: Chain A: V.60, H.61, S.62, W.63, W.69, W.83, F.85 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:W.63, A:W.69, A:W.69, A:W.83 Hydrogen bonds: A:H.61, A:W.63

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chamberlain, P.P. et al., Structural Basis for Responsiveness to Thalidomide-Analog Drugs Defined by the Crystal Structure of the Human Cereblon:DDB1:Lenalidomide Complex. to be published

Release Date

2014-08-06

Peptides

Protein cereblon: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Protein cereblon

Related Entries With Identical Sequence